Peptide synthesis is a process of creating short sequences of polypeptides by adding one amino acid at a time. This process is useful for creating specific sequences that represent epitopes of certain protein domains that may or may not be modified by moieties, such as phosphate groups. Peptide synthesis has become one of the most important methodologies in bio-organic chemistry for research and diagnosis. Moreover, increasing incidence of infectious diseases is expected to boost the market growth. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC) in February 2020, reports that the number of visits with infectious and parasitic diseases to physician offices as the primary diagnosis were 15.5 million in 2016 in the U.S.
The global peptide synthesis market is estimated to be valued at US$ 348.9 million in 2020 and is expected to exhibit a CAGR of 6.6% during the forecast period (2020-2027).
Figure 1. Global Peptide Synthesis Market Share (%), By Region, 2020
Inorganic strategies such as collaborations by market players for peptide synthesis is expected to propel growth of the global peptide synthesis market
Major players are focusing on expanding their business with inorganic strategies such as collaborations and this is expected to boost the market growth over the forecast period. For instance, in January 2018, Imcyse SA, a clinical-stage biotech company based in Belgium entered into a collaboration with leading multinational pharmaceutical corporation, Pfizer, Inc. The collaboration aimed at development of a certain modified peptide called Imotope. This particular peptide is synthesized for treating rheumatoid arthritis and other chronic diseases.
Moreover, increasing incidence of cancer cases is expected to boost the market growth. For instance, according to an article published by the World Health Organization in 2018, 18.1 million new cancer cases are reported every year across the globe. Among these, 300,000 cases are diagnosed among children aged 0 to 19 years.
Peptide Synthesis Market Report Coverage
| Report Coverage |
Details |
| Base Year: |
2019 |
Market Size in 2020: |
US$ 348.9 Mn |
| Historical Data for: |
2016 to 2019 |
Forecast Period: |
2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: |
6.6% |
2027 Value Projection: |
US$ 546.3 Mn |
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
| Segments covered: |
- By Product:
- Reagents & Consumables
- Equipment: Peptide Synthesizers, Lyophilizers, Chromatography Equipment.
- By Technology: Solid Phase, Liquid Phase, Hybrid & Recombinant.
- By Application:
- Therapeutics: Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, Others.
- Diagnosis
- Research
- By End User: Pharmaceutical and Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), Academic and Research Institutes.
|
| Companies covered: |
GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB
|
| Growth Drivers: |
- Rising incidence of acute and chronic diseases
- Product development and ongoing trials for peptide synthesis
|
| Restraints & Challenges: |
- Lack of regulations for the peptide synthesis
|
Figure 2. Global Peptide Synthesis Market Share (%), By Product, 2020
Increasing cancer cases in North America is expected to boost the market growth
North America is expected to hold dominant position in the global peptide synthesis market, owing to increasing new cases of cancer in the region. For instance, according to an article published by the American Cancer Association in 2018, reports that around 1,735,350 new cancer cases were diagnosed and 609,640 cancer deaths occurred in the U.S.
Global Peptide Synthesis Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector, which has been impacted significantly by the COVID-19 pandemic.
The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.
As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the global peptide synthesis market during the forecast period.
Key Players
Major players operating in the global peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others.
Peptide synthesis is characterized as the formation of a peptide bond between two amino acids. Peptide synthesis most often occurs by coupling the carboxyl group of the incoming amino acid to the N-terminus of the growing peptide chain. Peptide synthesis is a common approach in even high-throughput biological research and product and drug development.
Market Dynamics
Rising incidence of metabolic disorders such as diabetes is expected to drive the peptide synthesis market growth. For instance, according to an article published by the journal Diabetes Research and Clinical Practice - 'Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition in September 2019, 463 million people were estimated to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
However, sustainability in synthetic peptide production is expected to hinder the market growth. For instance, according to an article published by the ProteoGenix in November 2019, reports that development of sustainable and efficient catalytic methods is the major challenge in peptide synthesis.
Key features of the study:
- This report provides in-depth analysis of the global peptide synthesis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global peptide synthesis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market.
Detailed Segmentation:
- Global Peptide Synthesis Market, By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- Global Peptide Synthesis Market, By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- Global Peptide Synthesis Market, By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- Global Peptide Synthesis Market, By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- Global Peptide Synthesis Market, By Region:
- North America
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Latin America
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GenScript Biotech Corporation.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Merck KGaA
- ThermoFisher Scientific Inc.
- Syngene
- Lonza
- Novo Nordisk A/S
- Bachem Holding AG
- Gyros Protein Technologies
- Creative Diagnostics
- CEM Corporation
- PuroSynth
- AAPPTec
- Biotage AB
“*” marked represents similar segmentation in other categories in the respective section.
